Corbus Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRBP and other ETFs, options, and stocks.About CRBP
Corbus Pharmaceuticals Holdings, Inc. is an oncology company, which engages in research, development, and commercializing therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells, and CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity.
CEOYuval Cohen
CEOYuval Cohen
Employees28
Employees28
HeadquartersNorwood, Massachusetts
HeadquartersNorwood, Massachusetts
Founded2009
Founded2009
Employees28
Employees28
CRBP Key Statistics
Market cap88.47M
Market cap88.47M
Price-Earnings ratio-1.74
Price-Earnings ratio-1.74
Dividend yield—
Dividend yield—
Average volume110.61K
Average volume110.61K
High today$7.44
High today$7.44
Low today$7.17
Low today$7.17
Open price$7.38
Open price$7.38
Volume90.39K
Volume90.39K
52 Week high$61.90
52 Week high$61.90
52 Week low$4.64
52 Week low$4.64
Analyst ratings
100%
of 10 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own CRBP. This list is generated using Robinhood data, and it’s not a recommendation.